NHI Company Profile and Key Details

Short-term trend indicators are bearishly aligned (SMA20 5.47%, SMA50 7.22%, SMA200 11.44%). The stock’s 14-day RSI is 66.31 (firm momentum), while the ATR of 2.01 points to higher daily volatility. The stock remains currently trading near 52-week highs, trading 1.62% below its high and over 29.18% above its low. Average 10-day trading volume of 244.52 thousand shares is slightly above the 3-month average of 200.79 thousand, indicating heightened recent market interest.

National Health Investors, Inc. has 47.47 million shares outstanding. The public float is 43.92 million shares, elevated short interest at 4.63% of float. This equals 1.87 million shares. The short ratio is 7.72 days. Institutional investors hold 76.75% of the float. Insiders own 2.17%. ADAMS W ANDREW holds 759.78 thousand shares, ADAMS ROBERT G has 180.55 thousand shares and SWAFFORD CHARLOTTE A has 110.18 thousand shares.

National Health Investors, Inc. generated EPS of $3.17 over the past year. Five-year average earnings growth is -3.17%. Wall Street analysts project EPS growth of 4.09% annually over the next five years. The latest quarter delivered EPS of $1.32. The next quarter is forecast at $0.79. Next year's EPS is expected at -$8.69. Analyst sentiment is bullish. Analyst rating data shows there are 4 Strong Buy ratings, 2 Buy ratings, 3 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $90.00 to $76.00. The high target offers 6.81% upside. The low target suggests -9.8% downside. The mean target is $83.44. This offers -0.97% upside. National Health Investors, Inc. earnings surprise history is a mixed track record. The quarter that ended November 06, 2025, missed forecasts by 6.45%. The prior quarter beat by 5.17%. Over the last six quarters, Apple has recorded several small beats. These include -26.36% in August 06, 2024.

National Health Investors, Inc. last paid a dividend of 3.64 per share, this equals a trailing yield of roughly 5.15%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $148.58. This means the shares are trading below this model’s fair value.

National Health Investors, Inc. (NYSE:NHI) closed at $84.26 USD, gaining $2.76 (3.39%) from the previous close of $81.50. The stock is currently trading near its 52-week high $65.22 and $84.78. With a market capitalization of about $4.01 billion, National Health Investors, Inc. is classified as a mid-cap and shows lower-than-market volatility (beta ~0.67). Key stats such as the average daily volume over the past year has been around 211.33 thousand shares, trading with heavier-than-usual volume. Headquartered in Murfreesboro, TN, National Health Investors, Inc. operates in the Real Estate sector and the REIT - Healthcare Facilities industry. Led by CEO D. Eric Mendelsohn, the company employs approximately 30 people and listed since October 09, 1991. Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments.

National Health Investors, Inc. trades at a P/E ratio of 27.17, slightly below the S&P 500 average, with a price-to-sales ratio of 11.3 and a price-to-book ratio of 2.7 suggesting the stock is closer to book value. The P/FCF stands at 18.28, also above market averages.

Our AI price prediction model suggests that National Health Investors, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -1.85%, with price expected at $82.70 by February 18, 2026, within a range of $81.78 to $83.73 3-Month Outlook: Projected rise of 35.11%, reaching $113.84 by May 05, 2026, with a range of $111.16 to $117.22. 1-Year Outlook: Projected gain of 7.39%, with price at $90.49 by February 04, 2027, within a range of $88.38 to $92.75.

National Health Investors, Inc. (NYSE:NHI) shares are flat 4.36% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows National Health Investors, Inc. trading at a premium to the broader market with a P/E of 27.17. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $69.66, suggesting -17.33% downside. Our AI forecast model points to short-term weakness (-1.85% over two weeks), a medium-term rise (35.11% over three months), and a longer-term gain (7.39% over one year), with expected trading ranges indicating moderate volatility.